Pharmaust Ltd
ASX:PAA
Pharmaust Ltd
ASX:PAA
Price:
0.165
AUD
-8.33%
Market Closed
Market Cap:
AU$81.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Pharmaust Ltd
ASX:PAA
|
AU |
|
Mineros SA
TSX:MSA
|
CO |
|
Verite Co Ltd
TSE:9904
|
JP |
|
Dynacons Systems and Solutions Ltd
NSE:DSSL
|
IN |
|
Advantage Solutions Inc
NASDAQ:ADV
|
US |
|
KoreaGasCorp
KRX:036460
|
KR |
|
L
|
LGB Forge Ltd
NSE:LGBFORGE
|
IN |
|
UPC Technology Corp
TWSE:1313
|
TW |
|
Doma Holdings Inc
NYSE:DOMA
|
US |
Relative Value
There is not enough data to reliably calculate the relative value of PAA.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PAA
Relative Value
Base Case
Not Available
Multiples Across Competitors
PAA Competitors Multiples
Pharmaust Ltd Competitors
Pharmaust Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Pharmaust Ltd
ASX:PAA
|
81.2m AUD | 93.7 | -10.6 | -12.3 | -12.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD | 13.3 | 41.9 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.7B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.4 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 4.9 | 28.2 | 15.7 | 22.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.5B CHF | 5.2 | 21 | 13 | 16.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10.1 | 7.5 | 8.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
